May 1, 2010
and now, from your friendly jellyfish...or maybe not...
So apparently sweet furry animals aren't the only creatures we should be grateful to for MS treatments...still, the thought of being stung by these guys (or bees, another selfless creature in research) is more offputting than my daily copaxone shots...
Madison, Wis (May 1, 2010)- Quincy Bioscience, the biotechnology company responsible for the development of apoaequorin as a neuroprotective compound, is sponsoring the National Multiple Sclerosis Society in their fight to raise awareness through the Multiple Sclerosis MS Walk in Madison, Wisconsin on May 2. MS is a chronic, often disabling, disease that attacks the central nervous system (CNS), which is made up of the brain, spinal cord, and optic nerves.
Quincy Bioscience staff will be presenting and distributing important recruitment information for the MS HOPE Trial, a recently launched study by Quincy Bioscience. MS supporters can stop by the Quincy Bioscience booth to learn more about MS Hope Trials and how the jellyfish protein apoaequorin may improve the quality of life for those with MS.
Mark Underwood, president of Quincy Bioscience became interested in the jellyfish protein while majoring in Psychology at the University of Wisconsin-Milwaukee. After reading an article that linked the stings of jellyfish with the symptoms of MS, he decided to pursue this study further. Underwood explains, “The importance of finding answers is at an all time high. Events such as these can bring the community together to effectively raise awareness of MS and we at Quincy Bioscience want to bring hope to the MS community.”
Quincy Bioscience encourages the community to come out, raise awareness and support the cause for Multiple Sclerosis. The walk will be held at Warner Park in Madison, WI on Sunday, May 2, 2010 staring at 9 a.m. and is open to the public.
About The Wisconsin Chapter of the National Multiple Sclerosis Society
The Wisconsin Chapter of the National Multiple Sclerosis Society is a community of individuals who are committed to achieving a world free of MS. The Chapter helps over 10,000 individuals throughout 68 countries throughout Wisconsin impacted by MS to move their lives forward. The Wisconsin MS chapter provides comprehensive support services and educational programs to people with MS, their family and friends, and raise funds locally to support the National MS Society’s research initiatives.
About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wisconsin and is focused on the discovery, development and commercialization of novel compounds to fight the aging process. HOPE Trials is the research arm of Quincy Bioscience.
The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience has developed health applications of the jellyfish protein apoaequorin for dietary supplement.
Picture credit: http://lesleehorner.files.wordpress.com/2009/12/jellyfish2.jpg